Investigation of mutations in Exon 7,8 and Exon 9 of FHIT Gene in laryngeal squamous cell carcinoma
نویسندگان
چکیده
The purpose of this study was to assess and explain the relationship between molecular changes occurring in squamous cell laryngeal carcinoma. Furthermore, we were revealed the role of FHIT gene response in the development and progression of squamous cell laryngeal carcinoma, and genes based exons 7,8 and 9 in tumour stage and histopathologic grade. In this study was used 50 blood samples for control and 26 patients with laryngeal squamous cell carcinoma. Briefly, for this purpose, we primarily aimed researching or evaluating exon 7 (C/T), exon 8 (T/C) and exon 9 (A/G) homozygous deletions of FHIT gene exons. Mutations were examined with polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) and RT-PCR based HRM technigues. At the end of the HRM analysis, was observed a significant mutation in the groups of patients. L4 and L19 in the number and before the results of SSCP individuals identified as benign according to the results of HRM. In this study, exon 7 and 9 healthy individuals and squamous cell laryngeal carcinoma were observed any difference between individuals in terms of mutation. The pathology of the case was low differentiation. But in addition to this findings, the present findings highlight that the FHIT gene partially related to target for analysis in case with laryngeal squamous cell carcinoma. According to results of analyses, we idendified a link in between the exon 8 and exon 9 of FHIT gene. Abbreviations: SCC: squamous cell carcinoma; PCR-SSCP: polymerase chain reaction single-strand conformation polymorphism; HRM: high-resolution melting
منابع مشابه
Detection of Mutations in Exons 5 and 8 of Tumor Suppressor Tp53 Gene in Patients with Squamous Cell Carcinoma of Lung Hospitalized in Afzalipour Hospital, Kerman, Iran
Introduction: Despite improvements in the diagnosis and treatment of lung cancer in the past two decades, it has remained the most common cause of death from cancer worldwide. Among all genes that are mutated in lung cancer, TP53 located on chromosome 17P13/1 has a significant diagnostic and prognostic value. TP53 mutations have been extensively studied in lung cancer and TP53 mutational spectr...
متن کاملThe Prevalence of P53 Mutations in Laryngeal Cancer in Kerman
Background &Aims: Laryngeal cancer is the second common cancer of respiratory tract, following the lung cancer. Carcinogenesis is a complex multistage process; molecular genetics has provided the evidence that activation of proto-oncogene and loss or inactivation of tumor suppressor genes (TSG) are involved in a large number of malignancies. One of the earliest significant tumor suppressor gene...
متن کاملPrevalence of Nucleotide Alterations of EGFR Gene in Patients with Esophageal Squamous Cell Carcinoma in Kerman
Background & Aims: Esophageal Cancer is the sixth fatal cancer in the world. Squamous and adenocarcinoma account for 95% of esophageal cancer. The expression of EGFR has a role in the pathophysiology of epidermal-based malignancies such as esophageal cancer. EGFR is also an important criterion in the evaluation of disease staging and prognosis. The aim of this study was to survey the prevalence...
متن کاملبررسی جهشهای رایج ژنهای KRAS و BRAF در بیماران مبتلا به کارسینومای بافت سنگفرشی سر و گردن
Background: Head and neck squamous cell carcinoma (HNSCC) is the malignancy of squamous cells (the epidermal layer of skin) in cavities in head and neck includes: larynx, pharynx, paranasal sinuses and oral cavity. The main goal of this research was to understand the effect of mutations in two important genes (KRAS and BRAF) in RAS/MAP kinase (EGFR) signaling pathway in tumor cells with head an...
متن کاملChromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.
AIMS To study the loss of heterozygosity at the short arm of chromosome 3 in primary tumours from patients with squamous cell carcinoma of the head and neck; to determine whether the FHIT gene, mapped to 3p14.2 and the CTNNB1 (beta-cat) gene, mapped to 3p21, are deleted or mutated in these tumours. METHODS DNA was extracted from fresh tumours. Loss of heterozygosity was assessed by microsatel...
متن کامل